FDA approves first treatment for Erdheim-Chester Disease

Author(s):

fda treatment erdheim chester disease cancer blood

On Nov. 6, the U.S. Food and Drug Administration (FDA) expanded approval of Zelboraf (vemurafenib) to treat certain adult patients with Erdheim-Chester Disease. Read more via Fda.gov.

LEAVE A REPLY

Please enter your comment!
Please enter your name here